340 results on '"Stevenson, Donald D"'
Search Results
2. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature
3. Classification of Reactions to Nonsteroidal Antiinflammatory Drugs
4. Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease
5. Introduction: Szczeklik’s Contributions to Our Understanding of Aspirin, NSAIDs, Asthma, and Allergy
6. Characterization of aspirin allergies in patients with coronary artery disease
7. Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease
8. Predicting outcomes of oral aspirin challengesin patients with asthma, nasal polyps, andchronic sinusitis
9. Aspirin sensitivity and desensitization for asthma and sinusitis
10. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges
11. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease
12. Pathogenesis of aspirin-exacerbated respiratory disease
13. Aspirin desensitization in patients with AERD
14. Aspirin sensitivity
15. Aspirin-Exacerbated Respiratory Disease: Update on Pathogenesis and Desensitization
16. Aspirin-induced asthma
17. Effect of leukotriene modifier drugs on the safety of oral aspirin challenges
18. Clinical and pathologic perspectives on aspirin sensitivity and asthma
19. Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease
20. Methicillin-resistant Staphylococcus aureus pelvic abscesses in a female after gynecologic pelvic surgery
21. Does suppression of IL-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment?
22. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease
23. Hydroxyurea in the treatment of Churg-Strauss syndrome
24. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease
25. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
26. Selection of patients for aspirin desensitization treatment
27. Failure to maintain an aspirin-desensitized state in a patient with aspirin-exacerbated respiratory disease
28. Evidence-based protocols for oral NSAID challenges
29. Role of aspirin and other nonsteroidal anti-inflammatory drugs in aspirin-exacerbated respiratory disease
30. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease
31. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease
32. Aspirin and NSAID sensitivity
33. Aspirin Sensitivity: Implications for Patients With Coronary Artery Disease
34. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management
35. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease
36. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease
37. Introduction
38. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease
39. The Safety of Celecoxib in Patients With Aspirin-Sensitive Asthma
40. Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist: A Randomized, Double-Blind, Placebo-Controlled Trial
41. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes
42. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma
43. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics
44. 5ʼ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States
45. Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics
46. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses
47. Monosodium glutamate sensitivity in asthma
48. Aspirin-induced asthma: Advances in pathogenesis and management
49. Aspirin Desensitization: Faster Protocols for Busy Patients
50. High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.